CD Diagnostics

About:

CD Diagnostics develops assays for orthopedic surgeons and rheumatologists for greater diagnostic confidence in joint fluid analysis.

Website: http://cddiagnostics.com

Twitter/X: CDDiagnostics

Top Investors: Ben Franklin Technology Partners of Southeastern Pennsylvania

Description:

CD Diagnostics is developing assays for orthopaedic surgeons and rheumatologists who would like greater diagnostic confidence in joint fluid analysis. Unlike current technologies, which often yield vague and ambiguous results, CygnaSure™, our lead product, offers orthopaedic surgeons and rheumatologists a rapid, accurate and reliable diagnostic answer.

Total Funding Amount:

$6.81M

Headquarters Location:

Claymont, Delaware, United States

Founded Date:

2008-11-01

Contact Email:

info(AT)cddiagnostics.com

Founders:

Carl Deirmengian

Number of Employees:

11-50

Last Funding Date:

2012-09-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai